BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 11818567)

  • 1. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.
    Roberts RB; Min L; Washington MK; Olsen SJ; Settle SH; Coffey RJ; Threadgill DW
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1521-6. PubMed ID: 11818567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
    Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
    Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in Apc(Min/+) mice.
    Alferez D; Wilkinson RW; Watkins J; Poulsom R; Mandir N; Wedge SR; Pyrah IT; Smith NR; Jackson L; Ryan AJ; Goodlad RA
    Mol Cancer Ther; 2008 Mar; 7(3):590-8. PubMed ID: 18347145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betacellulin stimulates growth of the mouse intestinal epithelium and increases adenoma multiplicity in Apc+/Min mice.
    Dahlhoff M; Horst D; Gerhard M; Kolligs FT; Wolf E; Schneider MR
    FEBS Lett; 2008 Aug; 582(19):2911-5. PubMed ID: 18656477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.
    Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR
    Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1370):915-23. PubMed ID: 9684289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice.
    Hassan AB; Howell JA
    Cancer Res; 2000 Feb; 60(4):1070-6. PubMed ID: 10706126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.
    Silverman KA; Koratkar R; Siracusa LD; Buchberg AM
    Genome Res; 2002 Jan; 12(1):88-97. PubMed ID: 11779834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus.
    Koratkar R; Pequignot E; Hauck WW; Siracusa LD
    Cancer Res; 2002 Oct; 62(19):5413-7. PubMed ID: 12359746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q; Ishikawa TO; Oshima M; Taketo MM
    Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
    Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
    Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.
    Musteanu M; Blaas L; Mair M; Schlederer M; Bilban M; Tauber S; Esterbauer H; Mueller M; Casanova E; Kenner L; Poli V; Eferl R
    Gastroenterology; 2010 Mar; 138(3):1003-11.e1-5. PubMed ID: 19962983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin.
    Shao J; Washington MK; Saxena R; Sheng H
    Carcinogenesis; 2007 Dec; 28(12):2476-83. PubMed ID: 17693663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant stanols induce intestinal tumor formation by up-regulating Wnt and EGFR signaling in Apc Min mice.
    Marttinen M; Päivärinta E; Storvik M; Huikko L; Luoma-Halkola H; Piironen V; Pajari AM; Mutanen M
    J Nutr Biochem; 2013 Jan; 24(1):343-52. PubMed ID: 22981369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.
    Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ
    Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
    Watson SA; Smith AM
    Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of guanylyl cyclase C, the receptor for Escherichia coli heat-stable enterotoxin, results in reduced polyp formation and increased apoptosis in the multiple intestinal neoplasia (Min) mouse model.
    Mann EA; Steinbrecher KA; Stroup C; Witte DP; Cohen MB; Giannella RA
    Int J Cancer; 2005 Sep; 116(4):500-5. PubMed ID: 15825168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
    Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
    Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.
    Hinoi T; Akyol A; Theisen BK; Ferguson DO; Greenson JK; Williams BO; Cho KR; Fearon ER
    Cancer Res; 2007 Oct; 67(20):9721-30. PubMed ID: 17942902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis.
    Koratkar R; Silverman KA; Pequignot E; Hauck WW; Buchberg AM; Siracusa LD
    Genomics; 2004 Nov; 84(5):844-52. PubMed ID: 15475263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.